Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Glandular and Epithelial

Explore clinical trials studying Neoplasms, Glandular and Epithelial. Study availability and eligibility vary by location and protocol.

45 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Glandular and Epithelial trial results

Active, not recruiting

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

NCT05617755

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adnexal Diseases, +29 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • U of Colorado Cancer Center - Anschutz Medical Campus Aurora, Colorado, United States
  • U of Iowa Health Care Iowa City, Iowa, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, not recruiting

TheraSphere With Durvalumab and Tremelimumab for HCC

NCT05063565

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • University of California San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 35 locations
View Trial Details
Active, not recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

NCT04198766

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +56 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • California Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, not recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04807166

Conditions
Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
Locations
  • Huai'an First People's Hospital Huai'an, China
  • Nanjing Drum Tower Hospital Nanjing, China
  • Zhongda Hospital Southeast University Nanjing, China
  • The First Affiliated Hospital of Soochow University Suzhou, China
View Trial Details

Related conditions